10 deadly king cobras spotted at 9,000 feet near Mount Everest, scientists in shock due to..., Experts call it sign of...
According to Bishnu Pandey from Nepal's Forestry Institute, king cobra eggs were found near the Gaurishankar Range just before the COVID-19 pandemic. Also, cobras have been seen in Jiri Municipality, which lies between 1,600 and over 5,000 meters in altitude. These snakes are the same species usually found in Nepal's Terai region, which is at a much lower elevation.
Many experts think this strange movement to higher areas could be a sign of climate change. As temperatures rise, snakes might be moving to cooler places for survival.
However, not all scientists agree completely. Dr. Ramesh Chinnasamy from India's Wildlife Institute says that while king cobras usually live in rainforests and are shy in nature, we can't say for sure that this change is due to climate change without deeper research. He explained that warmer weather can make snakes more active and possibly push them into new areas, but more studies are needed to understand if this is just a rare case or part of a bigger environmental shift.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
2 hours ago
- Time of India
New COVID variant Stratus (XFG) spreads in the US: Symptoms, risks, and what you need to know
As the United States experiences another wave of COVID-19, a variant named Stratus (XFG) has caught the attention of health authorities. Officially identified as XFG, this recombinant strain was first detected in Southeast Asia in January 2025. While initially flying under the radar in the US, XFG accounted for 14% of all cases by late June, making it the third most prevalent variant according to the Centers for Disease Control and Prevention (CDC). Globally, the World Health Organization ( WHO ) has added XFG to its monitoring list, though it continues to classify the variant's overall public health risk as low. Experts reassure that current COVID-19 vaccines remain effective against symptomatic and severe disease caused by this strain. What is the new covid variant in the US Stratus (XFG) and how is it different XFG is a recombinant variant, meaning it combines genetic material from two earlier strains: F.7 and LP.8.1.2. While LP.8.1.2 is now the second most common strain in the US, XFG is notable for its mutations that may help it evade the immune system. Importantly, experts emphasize that these mutations do not make XFG more dangerous. According to Dr. Subhash Verma, microbiology and immunology professor at the University of Nevada, XFG does not cause more severe illness or different symptoms compared to earlier Omicron variants. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Use an AI Writing Tool That Actually Understands Your Voice Grammarly Install Now Undo Health authorities classify the variant as low risk, but continued monitoring is essential to track its evolution. How fast is this covid variant As reported by USA Today, XFG's prevalence in the US has increased rapidly in recent months: March 2025: 0% of cases April 2025: 2% of cases May 2025: 6% of cases Late June 2025: 14% of cases Globally, the WHO reported a rise from 7.4% in early May to 22.7% by the end of June across 38 countries. Despite this growth, XFG has not surpassed the top two variants, but its upward trend underscores the importance of ongoing genomic surveillance and vaccine coverage. Symptoms of Stratus (XFG) variant As USA Today reported, know the familiar COVID-19 symptoms for XFG infections. These include: Fever or chills Cough Fatigue Sore throat Loss of taste or smell Nasal congestion Muscle aches Shortness of breath Headache Nausea or vomiting Health officials stress that symptom patterns remain consistent with prior Omicron variants, and early testing, vaccination, and isolation are key to controlling spread. Prevention tips for Stratus (XFG) variant To reduce the risk of infection from the XFG variant (Stratus), follow these recommended safety measures: Stay up to date with COVID-19 vaccines: Ensure primary doses and booster shots are current, as vaccines remain effective against severe disease. Practice good hygiene: Regular handwashing, using hand sanitizer, and avoiding touching the face can reduce transmission. Wear masks in crowded or enclosed spaces: Especially in public transport, healthcare facilities, or areas with high case counts. Maintain physical distancing: Avoid close contact with people showing respiratory symptoms. Monitor symptoms and test early: Get tested if you experience fever, cough, fatigue, or other COVID-related symptoms. Isolate if infected: Follow local health guidelines to prevent spreading the virus to others. Ventilate indoor spaces: Increase airflow in homes, offices, and public spaces to reduce viral concentration. Disclaimer : The information provided in this article is for general educational purposes only and is based on data available from the reputable news sources as of August 2025. It should not be considered medical advice. Always consult healthcare professionals for personal guidance on COVID-19 prevention, testing, and treatment. Also read | Sudden cardiac arrest in gyms: Causes, prevention tips, and urgent advisory issued for young athletes by Punjab government
Time of India
5 hours ago
- Time of India
AIIMS-led study finds infections contracted in hospital due to catheter use prevalent across India
New Delhi: Bloodstream infections acquired during a hospital stay due to the use of a catheter are prevalent across ICUs in India and are often caused by microbes having a high level of antibiotic resistance, according to a study led by the All India Institute of Medical Sciences, New Delhi. Antibiotic resistance -- in which antibiotic drugs are rendered ineffective because disease-causing microbes have become immune to them -- can extend one's hospital stay and treatment costs, adding stress to a public healthcare system. Estimates published in The Lancet Global Health journal show that on average, around nine bloodstream infection events occur every 1,000 days that a central line -- a catheter inserted in a patient's large vein instead of an intravenous line -- was in place in the intensive care units (ICUs) of Indian hospitals. 'Central line-associated bloodstream infections', or CLABSI, are preventable infections -- often acquired from a hospital environment -- and significantly contribute to illness and death in low- and middle-income countries, including India. The researchers said that tracking rates of bloodstream infections in ICUs can help countries develop preventive measures suited to a healthcare system. However, setting up a surveillance that systematically tracks infections due to catheter use or other hospital-acquired infections calls for a significant amount of resources and is a challenge in low- and middle-income countries, including India, they said. The team analysed data from 200 intensive care units received by the Indian Healthcare-Associated Infections (HAI) surveillance network from 54 hospitals across the country over a period of seven years. "During the surveillance period from May 1, 2017, to April 30, 2024, 8,629 laboratory-confirmed CLABSI events, 3,054,124 patient-days and 977,052 central line-days were recorded. The overall pooled CLABSI rate was 8.83 per 1,000 central line-days," the authors wrote. Highest rates of bloodstream infections linked to central line catheter use were seen to occur during 2020-21, coinciding with the COVID-19 pandemic, which the researchers said may be due to overwhelmed ICUs, staff shortage and compromised infection prevention measures. The study -- first large-scale observational one, providing a standardised surveillance report of CLABSI in India -- provides a valuable opportunity for a quality improvement-based approach for the reduction of CLABSI, the authors said.
The Hindu
8 hours ago
- The Hindu
AIIMS-led study finds infections contracted in hospital due to catheter use prevalent across India
Bloodstream infections acquired during a hospital stay due to the use of a catheter are prevalent across ICUs in India and are often caused by microbes having a high level of antibiotic resistance, according to a study led by the All India Institute of Medical Sciences, New Delhi. Bloodstream infections Antibiotic resistance -- in which antibiotic drugs are rendered ineffective because disease-causing microbes have become immune to them -- can extend one's hospital stay and treatment costs, adding stress to a public healthcare system. Estimates published in The Lancet Global Health journal show that on average, around nine bloodstream infection events occur every 1,000 days that a central line -- a catheter inserted in a patient's large vein instead of an intravenous line -- was in place in the intensive care units (ICUs) of Indian hospitals. 'Central line-associated bloodstream infections', or CLABSI, are preventable infections -- often acquired from a hospital environment -- and significantly contribute to illness and death in low- and middle-income countries, including India. The researchers said that tracking rates of bloodstream infections in ICUs can help countries develop preventive measures suited to a healthcare system. However, setting up a surveillance that systematically tracks infections due to catheter use or other hospital-acquired infections calls for a significant amount of resources and is a challenge in low- and middle-income countries, including India, they said. Study highlights The team analysed data from 200 intensive care units received by the Indian Healthcare-Associated Infections (HAI) surveillance network from 54 hospitals across the country over a period of seven years. "During the surveillance period from May 1, 2017, to April 30, 2024, 8,629 laboratory-confirmed CLABSI events, 3,054,124 patient-days and 977,052 central line-days were recorded. The overall pooled CLABSI rate was 8.83 per 1,000 central line-days," the authors wrote. Highest rates of bloodstream infections linked to central line catheter use were seen to occur during 2020-21, coinciding with the COVID-19 pandemic, which the researchers said may be due to overwhelmed ICUs, staff shortage and compromised infection prevention measures. The study -- first large-scale observational one, providing a standardised surveillance report of CLABSI in India -- provides a valuable opportunity for a quality improvement-based approach for the reduction of CLABSI, the authors said.
